Evidence map›Paper›PMID 34903569›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2022

Endothelial Sphingosine-1-Phosphate Receptor 4 Regulates Blood-Brain Barrier Permeability and Promotes a Homeostatic Endothelial Phenotype.

Lena Hansen, Niklas Lohfink, Rajkumar Vutukuri, Roxane-Isabelle Kestner, Sandra Trautmann, Max Hecht, Pia Viktoria Wagner, Daniel Spitzer, Maryam Ibrahim Khel, Jadranka Macas and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Blocking S1PJournal of advanced research · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. The neurovasculature as a target in temporal lobe epilepsy.Brain pathology (Zurich, Switzerland) · 2023
    Review
  19. Article
  20. Adipokines in atherosclerosis: unraveling complex roles.Frontiers in cardiovascular medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Lena HansenInstitute of General Pharmacology and Toxicology, University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany.ORCID 0000-0001-7180-539X
Niklas LohfinkInstitute of General Pharmacology and Toxicology, University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany.ORCID 0000-0002-8427-2630
Rajkumar VutukuriInstitute of General Pharmacology and Toxicology, University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany.
Roxane-Isabelle KestnerInstitute of General Pharmacology and Toxicology, University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany.
Sandra TrautmannInstitute of Clinical Pharmacology, University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany.
Max HechtFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main 60596, Germany.
Pia Viktoria WagnerFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main 60596, Germany.
Daniel SpitzerInstitute of Neurology (Edinger Institute), University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany.ORCID 0000-0002-8915-4588
Maryam Ibrahim KhelInstitute of Neurology (Edinger Institute), University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany.
Jadranka MacasInstitute of Neurology (Edinger Institute), University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany.ORCID 0000-0002-1661-2525
Nerea FerreirósInstitute of Clinical Pharmacology, University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany.
Robert GurkeInstitute of Clinical Pharmacology, University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany.
Stefan GüntherMax Planck Institute for Heart and Lung Research, Department of Cardiac Development and Remodeling, Bad Nauheim 61231, Germany.
Waltraud PfeilschifterDepartment of Neurology, University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany waltraud.pfeilschifter@kgu.de kavi.devraj@kgu.de.
Kavi DevrajInstitute of Neurology (Edinger Institute), University Hospital, Goethe University Frankfurt, Frankfurt am Main 60528, Germany waltraud.pfeilschifter@kgu.de kavi.devraj@kgu.de.
Goethe University Frankfurt · DEFraunhofer Institute for Translational Medicine and Pharmacology · DEMax Planck Institute for Heart and Lung Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The precise regulation of blood-brain barrier (BBB) permeability for immune cells and blood-borne substances is essential to maintain brain homeostasis. Sphingosine-1-phosphate (S1P), a lipid signaling molecule enriched in plasma, is known to affect BBB permeability. Previous studies focused on endothelial S1P receptors 1 and 2, reporting a barrier-protective effect of S1P1 and a barrier-disruptive effect of S1P2. Here, we present novel data characterizing the expression, localization, and function of the S1P receptor 4 (S1P4) on primary brain microvascular endothelial cells (BMECs). Hitherto, the receptor was deemed to be exclusively immune cell associated. We detected a robust expression of S1P4 in homeostatic murine BMECs (MBMECs), bovine BMECs (BBMECs), and porcine BMECs (PBMECs) and pinpointed its localization to abluminal endothelial membranes via immunoblotting of fractionated brain endothelial membrane fragments. Apical S1P treatment of BMECs tightened the endothelial barrier

Indexed as

Blood-Brain BarrierSphingosine-1-Phosphate ReceptorsStrokeAnimalsCattleEndothelial CellsHomeostasisLysophospholipidsMiceMice, KnockoutPermeabilityPhenotypeReceptors, LysosphingolipidSphingosineSwineLysophospholipidsReceptors, LysosphingolipidSphingosineSphingosine-1-Phosphate Receptorsblood-brain barrierbrain microvascular endothelial cellsendothelial permeabilitymembrane receptor polaritysphingosine-1-phosphate receptor 4

Identifiers

PMID34903569
PMCPMC8916766
OpenAlexW4200176316

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.